Enhabit, Inc.
Enhabit, Inc. is a U.S. home health and hospice provider headquartered in Dallas, Texas, and spun out of Encompass Health in 2022. The company delivers Medicare-certified care in patients’ homes through two operating segments: Home Health and Hospice.
Fiscal year 2025 · change from previous year
Development 2020–2025
Business
Share of revenueSkilled in-home medical care including nursing, therapy, social work, and aide support.
End-of-life care services for terminally ill patients and family support.
Customers
Enhabit serves patients who need clinically managed care at home, typically after hospitalization, during recovery, or near end of life. Its payers are largely Medicare and Medicare Advantage plans, with referrals flowing from hospitals, physicians, and other healthcare providers. The business depends on patient volume, referral relationships, and reimbursement rates rather than direct consumer demand.
Patients needing skilled nursing, therapy, and aide services at home after illness or hospitalization.
Terminally ill patients and families buying symptom management and comfort-focused care.
Managed-care patients whose volumes depend on contract terms and payer relationships.
Hospitals, physicians, and care coordinators that direct patients to Enhabit’s agencies.
Strategy
Enhabit is focused on growing volume in existing markets, opening new locations, and improving reimbursement through payer innovation and Medicare Advantage contracting. It is also emphasizing operating efficiency, including visits-per-episode management in home health, while preserving scale and density in markets where it already has a presence.
Higher referral density improves utilization, brand awareness, and operating leverage.
New branches extend the footprint and create future scale in attractive markets.
Better reimbursement rates support margin stability in a regulated business.
Labor intensity and reimbursement pressure make productivity critical to profitability.
Geography
Enhabit operates entirely in the United States and had 249 home health locations and 117 hospice locations across 34 states as of year-end 2025. Its footprint is built around scale and density in selected local markets, with 111 hospice locations co-located within home health markets. Geography matters because reimbursement, referral access, and operating efficiency vary by state and by local market concentration.
Risks
Enhabit faces reimbursement pressure, especially from Medicare and Medicare Advantage rate changes, and its results depend heavily on patient volume and referral flow. It also operates in a fragmented, highly competitive market where larger providers and managed care companies can pressure volumes and pricing. Labor shortages, regulatory scrutiny, litigation, and execution risk around acquisitions, de novo openings, and leadership transition add further downside risk.
- Labor shortages and wage inflationImpact: HighLikelihood: High
Care delivery is labor intensive and staffing is central to service capacity and quality.
Exposure: Clinical staff and branch operations
- Medicare reimbursement pressureImpact: HighLikelihood: Medium
Home health and hospice revenue is heavily tied to government payment updates and rule changes.
Exposure: Home Health and Hospice segments
- Volume and referral declineImpact: HighLikelihood: Medium
The business depends on referrals, quality scores, and hospital readmission performance.
Exposure: All locations
- Competitive pressure from managed care and local providersImpact: MediumLikelihood: Medium
Competitors may have stronger scale, relationships, or direct home health offerings.
Exposure: Medicare Advantage volumes and key markets
- Integration and expansion executionImpact: MediumLikelihood: Medium
Acquisitions and de novo locations require approvals, capital, and operational integration.
Exposure: Growth strategy
- Leadership transitionImpact: MediumLikelihood: Medium
CEO transition can disrupt continuity, retention, and strategic execution.
Exposure: Corporate leadership
Accounting
Judgemental itemsReported revenue depends on expected reimbursement, denials, and audit outcomes.
Impact: Can affect net service revenue and receivables
Management estimates allowances for denied or under-review claims.
Impact: Affects bad debt-like expense and cash conversion
2025 included impairment charges for the Home Health reporting unit.
Impact: Reduces earnings and may signal weaker long-term assumptions
Certificates of need and similar assets can lose value if market assumptions change.
Impact: Can create non-cash charges and lower asset values
Hospice results can be affected by cap accruals and reversals.
Impact: Can cause volatility in quarterly hospice revenue and earnings
Similar listed companies
Publicly listed companies with a comparable business focus.
Encompass Health Corp
EHC · Services-Hospitals
Encompass Health Corp owns and operates inpatient rehabilitation hospitals that treat patients recovering from major injury or illness and needing intensive…
The Ensign Group, Inc
ENSG · Services-Skilled Nursing Care Facilities
Ensign Group is a holding company whose independent subsidiaries operate skilled nursing, senior living, and rehabilitative care facilities, plus ancillary…
Pennant Group, Inc.
PNTG · Services-Health Services
Enact Holdings, Inc.
ACT · Insurance Agents, Brokers & Service
InnovAge Holding Corp.
INNV · Services-Health Services
Envista Holdings Corp
NVST · Dental Equipment & Supplies
Envista Holdings Corp is a U.S.-based dental products company built around more than 30 brands, including Nobel Biocare, Ormco, DEXIS, and Kerr.
Last updated: 24/09/2026